Resolution: standard / high
Figure 3.
Incremental costs of using RDTs per malaria positive patient treated (base case):
based on total costs of RDT and antimalarials (artesunate plus sulfadoxine-pyrimethamine
and artemether-lumefantrine) when all suspected malaria cases are tested.
Zikusooka et al. Malaria Journal 2008 7:176 doi:10.1186/1475-2875-7-176
Download authors' original image